OneSource Specialty Pharma Partners with Xbrane Biopharma for Commercial Biosimilar Manufacturing
OneSource Specialty Pharma Limited has entered a strategic manufacturing partnership with Sweden-based Xbrane Biopharma AB to support commercial production of biosimilar products targeting EUR 23 billion in annual peak sales.